ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
Market capitalization of ChemoCentryx (CCXI)
Market cap: $3.73 Billion
As of April 2024 ChemoCentryx has a market cap of $3.73 Billion. This makes ChemoCentryx the world's 3076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ChemoCentryx from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.73 B | |
| 2022 | $3.73 B | 46.64% |
| 2021 | $2.54 B | -40.5% |
| 2020 | $4.28 B | 79.89% |
| 2019 | $2.38 B | 331.09% |
| 2018 | $0.55 B | 90.45% |
| 2017 | $0.29 B | -17.98% |
| 2016 | $0.35 B | -1.16% |
| 2015 | $0.35 B | 20.61% |
| 2014 | $0.29 B | 19.5% |
| 2013 | $0.24 B | -37.56% |
| 2012 | $0.39 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.16 B | 9,318.44% | 🇺🇸 USA |
 Pfizer PFE | $143.82 B | 3,746.60% | 🇺🇸 USA |
 AbbVie ABBV | $282.63 B | 7,458.79% | 🇺🇸 USA |
 Amgen AMGN | $144.81 B | 3,772.87% | 🇺🇸 USA |
 Biogen BIIB | $30.41 B | 713.44% | 🇺🇸 USA |
 Merck MRK | $332.33 B | 8,788.05% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $90.90 B | 2,331.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.98 B | 2,146.23% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.64 B | 318.33% | 🇮🇱 Israel |